RxDoctor Payments DataLook up a doctor →

Eric Scott, MD

Vascular Surgery · West Des Moines, IANPI 1386812931

Payments from drug & device makers

$642,076in general payments, 2019–2025

Across 744 payments — averaging $863.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$560K
  • Abbott$57K
  • Boston Scientific$9K
  • Inari Medical, Inc.$5K
  • Globus Medical$4K
  • Bard Peripheral Vascular, Inc.$3K
  • plus $4K from 16 others
$3,200in research payments, 2019–2025

Across 1 payment — averaging $3200.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$3K

What the payments were for

  • Consulting fees$26,1007%
  • Speaking & faculty fees$252,85064%
  • Travel & lodging$93,37724%
  • Food & beverage$20,2005%
  • Education$3490%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$642,076 in reported general payments places this provider in the 95th percentile of 38 vascular surgery providers in Iowa.

See all vascular surgery providers in Iowa

Medicare billing

Part B allowed, 2024
$929,452
Medicare patients
1,589
Services billed
4,074

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban84$66,759
EliquisApixaban20$11,327
ClopidogrelClopidogrel Bisulfate352$1,326
Cilostazol29$531
Atorvastatin Calcium15$106
Prednisone14$18
Simvastatin12$8

Paid to pharmacies, not to this prescriber.

Other vascular surgery in West Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →